One of animation’s most iconic fast-food disasters gets rebuilt for real. Watch the Chum Bucket take shape as a full-scale ...

Whoopi Goldberg’s significant weight loss using the GLP-1 drug Mounjaro has drawn attention to a visible side effect dubbed ...

The GLP-1 weight loss drugs revolutionizing the treatment of obesity, diabetes and a slew of other diseases come with a major caveat: They don’t work for everyone. Some people experience profound ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

A couple of decades ago, GLP-1 drugs were a specialised treatment for type-2 diabetes but, fast-forward to today, and they have become much more widespread, being sold to help people with obesity and ...

You’re not imagining it: GLP-1 receptor agonist medications—like Ozempic, Wegovy, and Zepbound—really are that ubiquitous. Nearly one in five American adults has taken this type of drug at some point, ...

One of the most enduring images of science fiction is the replacement of food with pills or other substances. It is a trope that has been depicted in numerous films, from 1930s musical Just Imagine to ...

Humans have long dreamed of a cure-all.Subscribe to The Post Most newsletter for the most important and interesting stories ...

While Lilly’s position in the obesity market and wider GLP-1 space has remained largely unshakeable in recent months, a crack in the company’s armor may be forming, according to at least one analyst.

For Sydney S., there is no way to describe rock bottom. She was her addiction and her addiction was her. Even from a young age, she says her memories contained one throughline: “Always wanting more.” ...

GLP-1 medications can alter bowel movements, with constipation and diarrhea being the most common side effects. These drugs slow digestion to help control appetite, which can lead to changes in stool ...

Researchers have found a protein that connects GLP-1 agonist drugs to long-term, broad genomic responses that can promote pancreatic health and resilience. GLP-1s are building a reputation as ‘wonder ...